[Skip to Content]
Menu
  • Overview
  • Program
  • Register
  • My Account
Menu
  • Home
  • SETAC North America 47th Annual Meeting Session/Event Gallery
  • Pharmaceuticals and Personal Care Products: Innovations in Risk Assessment, Regulation and Science
  • The Use of Monitoring Data for Surface Waters in Europe in Pharmaceutical Risk Assessments: The Need To Ensure Those Data Are Reliable and Relevant

5.14.T-03 - The Use of Monitoring Data for Surface Waters in Europe in Pharmaceutical Risk Assessments: The Need To Ensure Those Data Are Reliable and Relevant

Abstract

Measurements of pharmaceuticals in the environment are used for a wide range of purposes, from simple environmental status reporting to legally binding compliance monitoring and complex risk assessments. Compared with chemical ecotoxicity data, for which prescriptive frameworks of evaluation exist in many regulatory jurisdictions, these monitoring data, often termed chemical exposure data, generally receive only cursory assessment by practitioners. The evaluation of exposure datasets is not immune to the potential inconsistencies of expert judgments, introducing bias and bad practice, and leading to the drawing of spurious conclusions.

Exposure data should be evaluated for both reliability and relevance. Assessment of reliability refers to the inherent quality of the dataset, and evaluates the methods for sample collection, chemical analysis, and data processing steps. An understanding of the sampling design by which data were originally collected can help inform data processing decisions. This is especially important for micropollutants, such as pharmaceuticals, as exposure datasets are often fragmented and have been generated for many different purposes. Chemical exposure data relevancy assessment evaluates whether the dataset is appropriate for a specific end use or application; can it provide useful information for answering the questions that are posed by that application? This assessment typically considers the study design by which the data were originally collected and processed to establish what landscape and conditions are represented by the dataset and whether the dataset is appropriate for the purpose of aquatic risk assessment.

The CREED approach (Criteria for Reporting and Evaluating Exposure Datasets) was developed as part of a SETAC Technical Workshop in 2022, and provides ‘best practice’ for the evaluation of exposure data reliability and relevance. Here we provide examples of how CREED can be used to assess pharmaceutical monitoring data across Europe to support risk assessments, and what can happen if it is not used, and how that can influence the outcomes of risk assessments, through reference to European regulatory processes.

The approach means that data generators and researchers can understand how their measured pharmaceutical data can be used for risk assessments purposes. Further, it ensures that existing exposure datasets may be evaluated to provide consistent and transparent assessments of potential pharmaceutical risks.

Author(s)

Presenter: Iain Wilson, wca environment Ltd.,
Authors:
Iain Wilson wca environment Ltd. United Kingdom
Graham Merrington wca environment Ltd. United Kingdom




 
















5.14.T-03 - The Use of Monitoring Data for Surface Waters in Europe in Pharmaceutical Risk Assessments: The Need To Ensure Those Data Are Reliable and Relevant

Presentation Format

Platform presentation

  • Society of Environmental Toxicology and Chemistry
    setac.org

Cookies are small text files that are used to store small pieces of information. The cookies are stored on your device when the website is loaded on your browser. These cookies help us make the website function properly, make the website more secure, provide better user experience, and understand how the website performs and to analyze what works and where it needs improvement.